• 1
    Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: A summation. NCI Cytojournal 2008;5:6.
  • 2
    Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658665.
  • 3
    Wu HH, Jones JN, Osman J. Fine-needle aspiration cytology of the thyroid: Ten years experience in a community teaching hospital. Diagn Cytopathol 2006;34:9396.
  • 4
    Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology. Definitions, criteria, and explanatory notes. New York: Springer, 2010.
  • 5
    Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol 2009;117:195202.
  • 6
    Layfield LJ, Morton MJ, Cramer HM, Hirschowitz S. Implications of the proposed thyroid fine-needle aspiration category of “follicular lesion of undetermined significance”: A five-year mutli-institutional analysis. Diagn Cytopathol 2009;37:710714.
  • 7
    Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC. The Bethesda thyroid fine-needle aspiration classification system: 1 year at an academic institution. Thyroid 2009;19:12151223.
  • 8
    Broome JT, Solorzano CC. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: Evaluation of the Bethesda System for Reporting Thyroid Cytopathology. Surgery 2011;150:12341241.
  • 9
    Krane JF, VanderLaan PA, Faquin WC, Renshaw AA. The atypia of undetermined signifiance/follicular lesion of undetermined significance:malignant ratio. Cancer Cytopathol 2012;120:111116.
  • 10
    Ohori NP, Schoedel KE. Variability in the atypia of undetermined signifiance/ follicular lesion of undetermined significance diagnosis in the bethesda system for reporting thyroid cytopathology: Sources and recommendations. Acta Cytol 2011;55:492496.
  • 11
    Firat P, Cochand-Priolle B. The Bethesda system for reporting thyroid fine needle aspiration cytology: A study comparing the results of two centers from two different countries. Ann Pahol 2012;32:e29e34, 415–420.
  • 12
    Bongiovanni M, Crippa S, Baloch Z, et al. Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology. A multi-institutional study. Cancer Cytopathol 2012;120:117125.
  • 13
    Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: A necessary or optional category? Cancer Cytopathol 2009:117:298304.
  • 14
    Marchevsky AM, Walts AE, Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol 2010;38:252259.
  • 15
    Singh RS, Wang HH. Eliminating the ”Atypia of undetermined significance/ follicular lesion of undetermined significance” category from the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2011;136:896902.
  • 16
    Muddegowda PH, Lingegowda J, Natesan R, Kurpad R. Divide and rule: Cytodiagnosis of thyroid lesions using pattern analysis: A study of 233 cases. Diagn Cytopathol 2011;39:888895.
  • 17
    Olson M, Clark D, Erozan Y, Ai S. Atypia of undetermined significance: Institutional experience with the Bethesda System. CytoJournal 2011;8:S65.
  • 18
    Hudacko R, Heller K, Patel K, Ogilvie J, Cangiarella J, Simsir A. Review of the National cancer institute/Bethesda terminology system for thyroid cytology specimens: The New York university experience, with special focus on the indeterminate category follicular lesion of undetermined significance. CytoJournal 2011;8:S61.
  • 19
    Jing X, Roh MH, Knoepp SM, Zhao L, Michael CW. Minimizing the diagnosis of “follicular lesion of undetermined significance” and identifying predictive features for neoplasia. Diagn Cytopathol 2011;39:737742.
  • 20
    VanderLaan PA, Marqusee E, Krane JF. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol 2011;136:572577.
  • 21
    Lubitz CC, Faquin WC, Yang J, Mekel M, Gaz RD, Parangi S, et al. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid 2010;20:2531.
  • 22
    Abele JS, Levine RA. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol 2010;118:415422.
  • 23
    VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: Should repeated FNA be the preferred initial approach? Am J Clin Pathol 2011;135:770775.
  • 24
    Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: Distinct patterns and associated risk of malignancy. Cancer Cytopathol 2011;119:322327.
  • 25
    Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute Recommendations. Diagn Cytopathol 2010;38:731739.
  • 26
    Jing X, Knoepp SM, Roh MH, Hookim K, Placido J, Davenport R, et al. Group consensus review minimizes the diagnosis of "follicular lesion of undetermined significance" and improves cytohistologic concordance. Diagn Cytopathol 2012;40:10371042.
  • 27
    Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011;96:33903397.
  • 28
    Nikiforov YEW. Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med 2011;135:569577.
  • 29
    Hassell LA, Gillies EM, Dunn ST. Cytologic and molecular diagnosis of thyroid cancers: Is it time for routine reflex testing? Cancer Cytopathol 2012;120:717.
  • 30
    Luu MH, Fischer AH, Stockl TJ, Pisharodi L, Owens CL. Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis. Acta Cytol 2011;55:526530.